| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 21 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 21 |
| 2 | TACROLIMUS OINTMENT 0.1% | 21 |
| 3 | METHOTREXATE SODIUM | 20 |
| 4 | METHOTREXATE | 18 |
| 5 | MYCOPHENOLATE MOFETIL | 18 |
| 6 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 18 |
| 7 | RITUXIMAB | 17 |
| 8 | CIPROFLOXACIN | 16 |
| 9 | CIPROFLOXACIN HYDROCHLORIDE | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMPICILLIN AND SULBACTAM | 1 | 0.0011 |
| 1 | TAZAROTENE | 1 | 0.0008 |
| 2 | PSYLLIUM HUSK | 1 | 0.0007 |
| 3 | TREOSULFAN | 2 | 0.0007 |
| 4 | DICHLORPHENAMIDE | 1 | 0.0006 |
| 5 | VANCOMYCIN HYDROCHLORIDE | 5 | 0.0006 |
| 6 | SIROLIMUS | 8 | 0.0006 |
| 7 | CLINDAMYCIN HYDROCHLORIDE | 2 | 0.0006 |
| 8 | GANCICLOVIR SODIUM | 6 | 0.0006 |
| 9 | MILK THISTLE | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 42 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 22 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 19 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 18 |
| 4 | Fluoroquinolone Antibacterial [EPC] | 17 |
| 5 | Kinase Inhibitor [EPC] | 15 |
| 6 | Platinum-based Drug [EPC] | 15 |
| 7 | Thalidomide Analog [EPC] | 15 |
| 8 | Proton Pump Inhibitor [EPC] | 11 |
| 9 | Alkylating Drug [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 2 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 7 | 0.0003 |
| 3 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 4 | Echinocandin Antifungal [EPC] | 2 | 0.0002 |
| 5 | Provitamin D2 Compound [EPC] | 7 | 0.0002 |
| 6 | Selective T Cell Costimulation Blocker [EPC] | 1 | 0.0002 |
| 7 | Bismuth [EPC] | 1 | 0.0002 |
| 8 | Contrast Agent for Ultrasound Imaging [EPC] | 1 | 0.0002 |
| 9 | Asparagine-specific Enzyme [EPC] | 2 | 0.0001 |